I'm not saying I'm not dancing close to the door. These aquisitions are likely to be a sugar hit over the next couple of years, like you say no barriers to entry. They emphasied the R&D competitive advantage, but I more see their advantage as covering a lot of numbers on a roulette layout. Good odds, though a hit is a hit and it might not be from their stable.
I wouldn't short it, but if I did it would be in the low to mid 30s probably next year. Likely to be upgrades coming this year.
Goodluck.
- Forums
- ASX - By Stock
- Ann: 2018 Investor Day Presentation
I'm not saying I'm not dancing close to the door. These...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$53.48 |
Change
0.560(1.06%) |
Mkt cap ! $33.79B |
Open | High | Low | Value | Volume |
$53.31 | $53.68 | $52.97 | $20.25M | 379.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 529 | $53.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$53.48 | 152 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 697 | 53.480 |
14 | 463 | 53.470 |
9 | 448 | 53.460 |
12 | 388 | 53.450 |
6 | 380 | 53.440 |
Price($) | Vol. | No. |
---|---|---|
53.500 | 415 | 12 |
53.510 | 137 | 2 |
53.520 | 234 | 5 |
53.530 | 297 | 5 |
53.540 | 318 | 8 |
Last trade - 14.16pm 15/07/2024 (20 minute delay) ? |
Featured News
ALL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online